全球核酸标记市场规模（按产品、技术、应用、地区、范围和预测）

核酸标记的市场规模及预测

核酸标记市场规模预计在 2023 年达到 18.7 亿美元，到 2030 年将达到 47.5 亿美元，2024 年至 2030 年的复合年增长率为 9.7%。

核酸标记市场的全球市场推动因素

核酸标记市场的市场推动因素会受到多种因素的影响。

分子生物学研究进展：

主要驱动力之一是遗传学和分子生物学的不断发展。核酸标记对于基因表现分析、RNA定序和DNA定序等技术至关重要，从而推动了对该产品的需求。

扩大诊断应用：

随着核酸标记在 PCR（聚合酶炼式反应）、微阵列和原位杂交等诊断过程中的应用越来越多，市场也不断成长。这些方法对于识别许多疾病至关重要，包括癌症和传染病。

个人化医疗的需求日益增长：

个人化医疗的发展推动了核酸标记的需求，个人化医疗需要准确、精确的基因数据。对更有针对性的治疗和改善患者治疗效果的需求是这种发展的原因。

增加政府支持与资金：

得益于政府对蛋白质体学和基因组学研究的计画和资助，核酸标记产业正在不断扩大。生命科学研究的进步极大地得益于公共部门的资助。

创新：

透过标记程序的不断创新，包括创建新的萤光和放射性标记，核酸标记的效率和准确性正在提高。这些发展透过提高实验室和诊断设备的功能正在扩大市场。

扩大生物製药领域：

瞭解新药的效果和作用机制需要瞭解标籤技术。

遗传疾病发生率不断上升：

由于遗传疾病的盛行率不断上升以及相关的基因检测和研究需求，核酸标记市场正在不断增长。准确的标记对于识别基因改变和瞭解此类突变的后果至关重要。

限制全球核酸标记市场的因素

有几个因素可能会对核酸标记市场造成限制和课题。

标记试剂盒和试剂成本高：

对于预算紧张的小型实验室或学术机构来说，核酸标记试剂盒和试剂的高成本可能是一个主要障碍。

技术困难与复杂性：

核酸标记程序技术性很强且复杂，需要特定的知识和工具。它的复杂性可能会阻碍采用，特别是在基础设施或经验有限的环境中。

监理与道德问题：

围绕基因工程和研究的严格规定和道德问题可能会带来问题。克服这些规定所需的时间和费用可能会影响市场扩张。

认知与采用有限：

在某些地区，先进的核酸标记技术可能较不为人所知，也未广泛应用。这可能是由于缺乏教育、培训或无法获得现代研究方法和设备。

与替代技术的衝突：

用于标记和侦测商品的替代技术对市场构成竞争威胁。这些替代技术的发展可能会减少对传统核酸标记产品的需求。

智慧财产权问题：

有关专利和智慧财产权的问题也可能构成障碍。公司在使用某些标籤技术时可能会遇到法律课题或限制，这可能会阻碍市场成长和创新。

供应链中断：

核酸标记所需试剂和原料供应链的延迟可能会对市场产生不利影响。这可能是由于自然灾害、地缘政治动盪或其他意外事件造成的。

新兴市场饱和：

在市场已经饱和的新兴国家，市场发展可能受到限制。公司必须关注新兴市场，因为新兴市场也可能带来课题和不确定性。

目录

第 1 章全球核酸标记市场：简介

市场概况
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第四章 全球核酸标记市场展望

• 概述
• 市场动态
  • 驱动程式
  • 阻碍因素
  • 机会
• 波特五力模型
• 价值链分析
• 监理框架

第 5 章。

• 概述
• 试剂
• 套件
• 服务

6. 全球核酸标记市场（依技术）

• 概述
• PCR 方法
• 尼克翻译
• 随机引物 体外转录
• 逆转录
• 结束标记

第 7 章全球核酸标记市场（依应用）

• 概述 DNA定序
• 聚合酶炼式反应
• 萤光原位杂交（FISH）
• 微阵列 印迹 原位杂交
• 其他用途

第 8 章全球核酸标记市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第九章全球核酸标记市场的竞争格局

• 概述
• 公司市占率
• 供应商概况
• 主要发展策略

第十章 公司简介

• Agilent Technologies, Inc.
• Enzo Biochem, Inc.
• F. Hoffman-La Roche AG
• General Electric Company
• Merck KGaA（Germany）
• New England Biolabs
• Perkinelmer, Inc.
• Promega Corporation
• Thermo Fisher Scientific, Inc.
• Vector Laboratories

第 11 章附录

• 相关研究

Nucleic Acid Labeling Market Size And Forecast

Nucleic Acid Labeling Market size was valued at USD 1.87 Billion in 2023 and is projected to reach USD 4.75 Billion by 2030 , growing at a CAGR of 9.7% from 2024 to 2030. Global Nucleic Acid Labeling Market Drivers The market drivers for the Nucleic Acid Labeling Market can be influenced by various factors. These may include:

Research Advancements in Molecular Biology:

One of the main drivers is the ongoing development of genetic and molecular biology. Nucleic acid labeling is crucial to methods like gene expression analysis, RNA sequencing, and DNA sequencing, which drives up demand for the product.

Growing Applications in Diagnostics:

The market is growing as a result of the growing use of nucleic acid labeling in diagnostic processes such PCR (Polymerase Chain Reaction), microarrays, and in situ hybridization. These methods are essential for identifying a number of illnesses, such as cancer and infectious infections.

Growing Need for Personalized Medicine:

The need for nucleic acid labeling is being driven by the movement toward personalized medicine, which necessitates precise and accurate genetic data. The demand for more focused treatments and better patient outcomes is what is causing this development.

Increase in Government Support and Funding:

The nucleic acid labeling industry is expanding thanks to government programs and funding for proteomics and genomics research. The advancement of life sciences research is greatly aided by public sector funding.

Technological Innovations:

The efficiency and precision of labeling nucleic acids are improved by continuous technological breakthroughs in labeling procedures, such as the creation of new fluorescent and radioactive labels. Because these developments enhance the capacities of research and diagnostic instruments, the market is expanding.

Extension of the Biopharmaceutical Sector:

Another important driver is the biopharmaceutical sector's expansion, which depends on nucleic acid labeling for drug research and development procedures. grasp the effects and mechanisms of action of novel medications requires a grasp of labeling techniques.

Increased Prevalence of Genetic illnesses:

The market for nucleic acid labeling is seeing growth because to the increased prevalence of genetic illnesses and the resulting need for genetic testing and research. To identify genetic alterations and comprehend the consequences of such mutations, accurate labeling is essential.

Global Nucleic Acid Labeling Market Restraints

Several factors can act as restraints or challenges for the Nucleic Acid Labeling Market. These may include:

High Costs of Labeling Kits and Reagents:

For smaller research labs and academic institutions with tighter budgets, the high costs of labeling kits and reagents for nucleic acids can be a major obstacle.

Technical Difficulties and Complexity:

Nucleic acid labeling procedures can be highly technical and complex, requiring specific knowledge and tools. Adoption may be hampered by its complexity, especially in environments with inadequate infrastructure and experience.

Regulatory and Ethical Issues:

Tight regulations and moral issues pertaining to genetic engineering and research might be problematic. The expansion of the market may be impacted by the time and money required to navigate these rules.

Limited Awareness and Adoption:

Advanced nucleic acid labeling technologies may not be as well known or used as they could be in some areas. Lack of education, training, or access to the newest methods and instruments for study could be the cause of this.

Competition from Alternative Technologies:

Alternative technologies for marking and detecting goods are a competitive threat to the market. Developments in these substitute techniques may lessen the need for conventional nucleic acid labeling products.

Intellectual Property Problems:

Problems with patents and rights to intellectual property can also serve as barriers. Businesses may encounter legal issues or limitations when utilizing specific labeling technology, which can stifle market growth and innovation.

Disruptions to the Supply Chain:

The market may suffer if there are any delays in the supply chain for the reagents and raw materials needed for nucleic acid labeling. Natural catastrophes, geopolitical unrest, or other unanticipated events may be to blame for this.

Market Saturation in Developed Regions:

Growth prospects may be restricted in developed regions where the market is already saturated. Businesses could have to concentrate on developing markets, which can present unique difficulties and uncertainties of their own.

Global Nucleic Acid Labeling Market Segmentation Analysis

The Global Nucleic Acid Labeling Market is Segmented on the basis of Product, Technique, Application, And Geography.

Nucleic Acid Labeling Market, By Product

• Reagents and Kits:
• This segment includes various reagents and kits used for labeling nucleic acids, such as labeling reagents, probes and labels, enzymes, and others.
• Services:
• This segment comprises services related to nucleic acid labeling, including customization, consulting, and others.

Nucleic Acid Labeling Market, By Technique

• Radioactive Labeling:
• This technique involves the use of radioactive isotopes to label nucleic acids for various applications.
• Non-radioactive Labeling:
• This technique uses non-radioactive methods, such as fluorescent labeling, biotin-based labeling, and others, to label nucleic acids.

Nucleic Acid Labeling Market, By Application

• Microarray:
• Nucleic acid labeling is used in microarray technology for gene expression profiling and other genomic applications.
• Sequencing:
• Labeling is crucial in nucleic acid sequencing methods to identify and analyze nucleotide sequences.
• PCR: Polymerase chain reaction (PCR) applications often require nucleic acid labeling for amplification and detection purposes.
• FISH (Fluorescent In Situ Hybridization):
• FISH uses fluorescently labeled probes to detect and localize specific DNA sequences on chromosomes.
• In Situ Hybridization:
• In this technique, labeled nucleic acid probes are used to detect complementary DNA or RNA sequences in cells or tissues.
• Other Applications
• : This includes various other applications of nucleic acid labeling in research, diagnostics, and other fields.

Nucleic Acid Labeling Market, By Geography

• North America:
• This region includes the U.S. and Canada, which are major markets for nucleic acid labeling products and services.
• Europe
• : The European market comprises countries like the U.K., Germany, France, and others, where there is a significant demand for nucleic acid labeling.
• Asia Pacific:
• Countries like China, Japan, India, and others in the Asia Pacific region are witnessing growth in the nucleic acid labeling market.
• Latin America:
• Brazil, Mexico, and other Latin American countries contribute to the nucleic acid labeling market in this region.
• Middle East & Africa:
• The market in this region includes countries in the GCC, South Africa, and others, where nucleic acid labeling is used in various applications.

Key Players

• The major players in the Nucleic Acid Labeling Market are:
• Agilent Technologies, Inc.
• Enzo Biochem, Inc.
• F. Hoffman-La Roche AG
• General Electric Company
• Merck KGaA (Germany)
• New England Biolabs
• Perkinelmer, Inc.
• Promega Corporation
• Thermo Fisher Scientific, Inc.
• Vector Laboratories

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NUCLEIC ACID LABELING MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NUCLEIC ACID LABELING MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis
• 4.5 Regulatory Framework

5 GLOBAL NUCLEIC ACID LABELING MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Reagents
• 5.3 Kits
• 5.4 Services

6 GLOBAL NUCLEIC ACID LABELING MARKET, BY TECHNIQUE

• 6.1 Overview
• 6.2 PCR
• 6.3 Nick Translation
• 6.4 Random Primer
• 6.5 In Vitro Transcription
• 6.6 Reverse Transcription
• 6.7 End Labeling

7 GLOBAL NUCLEIC ACID LABELING MARKET, BY APPLICATION

• 7.1 Overview
• 7.2 DNA Sequencing
• 7.3 Polymerase Chain Reaction
• 7.4 Fluorescence in Situ Hybridization (FISH)
• 7.5 Microarrays
• 7.6 Blotting
• 7.7 in Situ Hybridization
• 7.8 Other Applications

8 GLOBAL NUCLEIC ACID LABELING MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL NUCLEIC ACID LABELING MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Share
• 9.3 Vendor Landscape
• 9.4 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Agilent Technologies, Inc.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Enzo Biochem, Inc.
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 F. Hoffman-La Roche AG
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 General Electric Company
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Merck KGaA (Germany)
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 New England Biolabs
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Perkinelmer, Inc.
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Promega Corporation
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Thermo Fisher Scientific, Inc.
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Vector Laboratories
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 Appendix

• 11.1 Related Research